Skip to main content
Quest Diagnostics

Multiple Malignancy-Associated Dermatomyositis Myositis-Specific Autoantibodies in Dermatomyositis

Multiple Malignancy-Associated Dermatomyositis Myositis-Specific Autoantibodies in Dermatomyositis

Authors: Choi J, Mir A, Wu B

Citation: JAAD Case Rep. 2025 Jun 16;62:134-135. doi: 10.1016/j.jdcr.2025.05.023.

Specialties: Dermatology, Oncology, Immunology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath Diagnostics, a subsidiary of Quest Diagnostics.

Related content

On-Demand Webinar
Specialized Lab Testing for Myositis
Publication
Refractory Antimelanoma Differentiation-Associated Gene 5 Antibody Negative Ulcerative Dermatomyositis Responsive to Mycophenolate Mofetil
On-Demand Webinar
Lab Testing for Overlapping Rheumatic Diseases: A Comprehensive Approach

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.